Search Results for: Oramed

Developing an oral Covid-19 vaccine

Israel’s Oramed (reported here previously) has launched Oravax – a joint venture with India’s Premas Biotech to develop a Covid-19 vaccine. The vaccine is administered orally (not injected) and targets 3 virus proteins, so should counter any mutations. Human trials … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Trial success for diabetes pill

Israel’s Oramed announced good results of its Phase 2b trials of ORMD-0801 treatment for Type 2 diabetes. Oramed will now discuss its Phase 3 plans with the US FDA. https://www.oramed.com/oramed-reports-positive-results-in-the-final-cohort-of-its-phase-2b-oral-insulin-trial/

Posted in Israel's Medical Achievements | Leave a comment

Oral insulin to replace injections

Israeli TV news about the innovative treatment from Israel’s Oramed that will make life better for many of the 400 million people with diabetes. http://www.israelnationalnews.com/News/News.aspx/214498#.V3uKKjUbNf4

Posted in Israel's Medical Achievements | Leave a comment

Success for diabetes treatment trial

Israeli biotech Oramed has reported success in the Phase IIb study of its insulin capsule.  Oramed highlighted that it was the first time an oral solution showed a significant drop in blood sugar at night.  Oral insulin will replace injected … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Treatment for diabetics in China

Israel’s Oramed has signed a deal worth $50 million that gives China’s Hefei Life Science & Technology (HLST) the rights to Oramed’s oral insulin capsule ORMD-0801 in China, Hong Kong and Macau. ORMD-0801 will help treat the large and growing … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

$50 million to market Israeli oral insulin

China’s Hefei has bought the rights to market the oral insulin capsules developed by Israel’s Oramed on completion of Phase III trials. In a deal worth over $50 million, Hefei gets exclusive rights to market the diabetes treatment in China, … Continue reading

Posted in Economy & Business | Leave a comment

Oral proteins get US patent

The United States Patent and Trademark Office has approved a patent from Israel’s Oramed for its invention, titled “Methods and Compositions for Oral Administrations of Proteins.” The patent is the basis for Oramed’s ORMD-0801 oral insulin for the early treatment … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Success in oral insulin study

Israeli bio-tech Oramed has announced that its Phase 2a clinical trial for its ORMD-0801 oral insulin capsule for the treatment of type 2 diabetes met all primary and secondary endpoints. The Phase 2b study will be carried out later this … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

A pill for Type 1 diabetes

Israeli biotech Ormed is developing oral medicines to treat conditions that normally require injections. Its flagship product, the ORMD-0801 insulin capsule for Type 1 (juvenile) diabetes has just successfully completed clinical trials. Ormed’s share price rose 115 percent on the … Continue reading

Posted in Israel's Medical Achievements | Leave a comment